Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermhaus Pharma is a Philippine-based pharmaceutical company specializing in the development, manufacturing, and marketing of dermatological and consumer healthcare products. The company is best known for its flagship sun protection brand, Dermplus, which offers a wide range of SPF-rated lotions and sprays tailored for tropical climates. In addition to sun care, Dermhaus produces therapeutic soaps and topical treatments for conditions such as acne, fungal infections, and hyperpigmentation. The company maintains a strong presence in both retail pharmacies and clinical dermatology channels across the Philippines, focusing on providing high-quality, affordable skincare solutions. Dermhaus integrates local manufacturing with targeted marketing to serve the specific dermatological needs of the Southeast Asian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermhaus.